First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults. - Cicconi P; Jones C; Sarkar E; Silva-Reyes L; Klenerman P; de Lara C; Hutchings C; Moris P; Janssens M; Fissette LA; Picciolato M; Leach A; et al. (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020)